Opus Genetics IRD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$65.54M-297% | -$16.52M+5.3% | -$17.45M-135% | -$7.42M+9.4% | -$8.19M+76.7% | ||
| $13K0.0% | $13K0.0% | $13K-7.1% | $14K+7.7% | $13K+30.0% | ||
| $1.46M+89.1% | $774K-5.1% | $816K-8.9% | $896K-1.9% | $913K+14.8% | ||
| -$12.73M-29.4% | -$9.83M-59.7% | -$6.16M+40.0% | -$10.27M-14.2% | -$8.99M-20.9% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $0— | $0— | $0— | $0— | $0-100% | ||
| $27.6M+14.5% | $24.11M+431% | $4.54M+401% | $906K-95.6% | $20.47M— | ||
| $14.87M+4.1% | $14.28M— | —— | —— | $11.47M+282% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Opus Genetics generate?
- Opus Genetics (IRD) generated -$39.0M in operating cash flow over the trailing twelve months.
- Where does Opus Genetics's cash flow data come from?
- Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
